1. You are here:  
  2. Home>
  3. PMCC Staff Publications

pmcc logo smlHere are the staff publications for November 2016, compiled December 6th.

 

 

Here are the staff publications for November 2016, compiled December 6th.

 

  1. Alsop K, Thorne H, Sandhu S, et al. A community-based model of rapid autopsy in end-stage cancer patients. Nature Biotechnology 2016;34:1010-4.
  2. Anderson MA, Blombery P, Seymour JF. Transformed Lymphoma. Hematology/Oncology Clinics of North America 2016;30:1317-32.
  3. ANZGOG and PORTEC Group, Blinman P, et al. Patients' and clinicians' preferences for adjuvant chemotherapy in endometrial cancer: an ANZGOG substudy of the PORTEC-3 intergroup randomised trial. British Journal of Cancer 2016;115:1179-85.
  4. Atkinson V, Long GV, Menzies AM, et al. Optimizing combination dabrafenib and trametinib therapy in BRAF mutation-positive advanced melanoma patients: Guidelines from Australian melanoma medical oncologists. Asia Pacific Journal of Clinical Oncology 2016;12 Suppl 7:5-12.
  5. Baumert BG, Hegi ME, van den Bent MJ, et al. Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study. Lancet Oncology 2016;17:1521-32.
  6. Bottai G, Raschioni C, Losurdo A, et al. An immune stratification reveals a subset of PD-1/LAG-3 double-positive triple-negative breast cancers. Breast Cancer Research 2016;18:121.
  7. Chan KL, Lokan J, Tam CS, Lew TE, Prince HM. Central nervous system immune reconstitution inflammatory syndrome after ibrutinib therapy for Richter transformation. Leukemia & Lymphoma 2017;58:207-10.
  8. Chen Y, Russell SM. Mediating signaling response to actin-mediated forces: Cas-L is causal in the T-cell response to forces triggered by antigen presentation. Immunology and Cell Biology 2016;94:905-6.
  9. D'Arcy FT, Leveridge M, O'Kane D, et al. Contrast Enhanced Ultrasonography in suspected renal colic: response. European Journal of Emergency Medicine 2016;23:458.
  10. Darido C, Georgy SR, Jane SM. The role of barrier genes in epidermal malignancy. Oncogene 2016;35:5705-12.
  11. Douglas AP, Slavin MA. Risk factors and prophylaxis against invasive fungal disease for haematology and stem cell transplant recipients: an evolving field. Expert Review of Anti-Infective Therapy 2016;14:1165-77.
  12. El-Galaly TC, Cheah CY, Hutchings M, et al. Uterine, but not ovarian, female reproductive organ involvement at presentation by diffuse large B-cell lymphoma is associated with poor outcomes and a high frequency of secondary CNS involvement. British Journal of Haematology 2016;175:876-83.
  13. Fennell M, Simpson KJ. Society of Biomolecular Imaging and Informatics Special Issue, October 2016. Assay and Drug Development Technologies 2016;14:437-8.
  14. Ferguson MT, Mallia A, Yap K, Wright S, Hicks RJ, Hofman MS. 'Hot spot' cardiac ischemia imaging with fluorodeoxyglucose positron emission tomography. Journal of Nuclear Cardiology 2016;23:1514-7.
  15. Halkett G, O'Connor M, Aranda S, et al. Communication skills training for radiation therapists: preparing patients for radiation therapy. Journal of Medical Radiation Sciences 2016;63:232-41.
  16. Hebbard AI, Slavin MA, Reed C, et al. The epidemiology of Clostridium difficile infection in patients with cancer. Expert Review of Anti-Infective Therapy 2016;14:1077-85.
  17. Hiller JG, Ismail HM, Hofman MS, Narayan K, Ramdave S, Riedel BJ. Neuraxial Anesthesia Reduces Lymphatic Flow: Proof-of-Concept in First In-Human Study. Anesthesia & Analgesia 2016;123:1325-7.
  18. Jakl L, Lobachevsky P, Vokalova L, Durdik M, Markova E, Belyaev I. Validation of JCountPro software for efficient assessment of ionizing radiation-induced foci in human lymphocytes. International Journal of Radiation Biology 2016;92:766-73.
  19. Jeong W, Haywood P, Shanmuganathan N, et al. Safety, clinical effectiveness and trough plasma concentrations of intravenous posaconazole in patients with haematological malignancies and/or undergoing allogeneic haematopoietic stem cell transplantation: off-trial experience. Journal of Antimicrobial Chemotherapy 2016;71:3540-7.
  20. Kader T, Goode DL, Wong SQ, et al. Copy number analysis by low coverage whole genome sequencing using ultra low-input DNA from formalin-fixed paraffin embedded tumor tissue. Genome Medicine 2016;8:121.
  21. Kenealy M, Patton N, Filshie R, et al. Results of a phase II study of thalidomide and azacitidine in patients with clinically advanced myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia (CMML) and low blast count acute myeloid leukemia (AML). Leukemia & Lymphoma 2017;58:298-307.
  22. Koay HF, Gherardin NA, Enders A. A three-stage intrathymic development pathway for the mucosal-associated invariant T cell lineage. Nature Immunology 2016;17:1300-11.
  23. Konert T, Vogel WV, Everitt S, et al. Multiple training interventions significantly improve reproducibility of PET/CT-based lung cancer radiotherapy target volume delineation using an IAEA study protocol. Radiotherapy and Oncology 2016;121:39-45.
  24. Konvinse KC, Phillips EJ, White KD, Trubiano JA. Old dog begging for new tricks: current practices and future directions in the diagnosis of delayed antimicrobial hypersensitivity. Current Opinion in Infectious Diseases 2016;29:561-76.
  25. Krasnec KV, Papenfuss AT, Miller RD. The UT family of MHC class I loci unique to non-eutherian mammals has limited polymorphism and tissue specific patterns of expression in the opossum. BMC immunology 2016;17:43.
  26. Lobachevsky P, Clark GR, Pytel PD, et al. Strand breakage by decay of DNA-bound 124I provides a basis for combined PET imaging and Auger endoradiotherapy. International Journal of Radiation Biology 2016;92:686-97.
  27. Manley L, Gibson L, Papa N, et al. Evaluation of pelvic floor muscle strength before and after robotic-assisted radical prostatectomy and early outcomes on urinary continence. Journal of Robotic Surgery 2016;10:331-5.
  28. Martin RF, Feinendegen LE. The quest to exploit the Auger effect in cancer radiotherapy - a reflective review. International Journal of Radiation Biology 2016;92:617-32.
  29. McCarthy MC, McNeil R, Drew S, et al. Psychological Distress and Posttraumatic Stress Symptoms in Adolescents and Young Adults with Cancer and Their Parents. Journal of Adolescent and Young Adult Oncology 2016;5:322-9.
  30. Murphy DG, Grummet JP. Planning for the post-antibiotic era - why we must avoid TRUS-guided biopsy sampling. Nature Reviews Urology 2016;13:559-60.
  31. Newbold A, Falkenberg KJ, Prince HM, Johnstone RW. How do tumor cells respond to HDAC inhibition? FEBS Journal 2016;283:4032-46.
  32. Ninkovic S, Cheah CY, Lasocki A, Harrison SJ. Engraftment syndrome manifesting as acute brachial neuropathy following high-dose chemotherapy for management of plasma cell myeloma. Leukemia & Lymphoma 2016;57:2942-5.
  33. O'Brien S, Jones JA, Coutre SE, et al. Ibrutinib for patients with relapsed or refractory chronic lymphocytic leukaemia with 17p deletion (RESONATE-17): a phase 2, open-label, multicentre study. Lancet Oncology 2016;17:1409-18.
  34. Pang JM, Gorringe KL, Fox SB. Reply to the Baader-Meinhof phenomenon in ductal carcinoma in situ of the breast. Histopathology 2016;69:523-4.
  35. Paul PJ, Raghu D, Chan AL, et al. Restoration of tumor suppression in prostate cancer by targeting the E3 ligase E6AP. Oncogene 2016;35:6235-45.
  36. Pogson EM, Delaney GP, Ahern V, et al. Comparison of Magnetic Resonance Imaging and Computed Tomography for Breast Target Volume Delineation in Prone and Supine Positions. International Journal of Radiation Oncology Biology Physics 2016;96:905-12.
  37. Quak E, Le Roux PY, Lasnon C, et al. Does PET SUV Harmonization Affect PERCIST Response Classification? Journal of Nuclear Medicine 2016;57:1699-706.
  38. Rebbeck TR, Friebel TM, Mitra N, et al. Inheritance of deleterious mutations at both BRCA1 and BRCA2 in an international sample of 32,295 women. Breast Cancer Research 2016;18:112.
  39. Reijneveld JC, Taphoorn MJ, Coens C, et al. Health-related quality of life in patients with high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study. Lancet Oncology 2016;17:1533-42.
  40. Rios AC, Fu NY, Cursons J, Lindeman GJ, Visvader JE. The complexities and caveats of lineage tracing in the mammary gland. Breast Cancer Research 2016;18:116.
  41. Smith LK, Thomas DW, Simpson KJ, Humbert PO. A Phenotypic High-Content Screening Assay to Identify Regulators of Membrane Protein Localization. Assay and Drug Development Technologies 2016;14:478-88.
  42. Southey MC, Goldgar DE, Winqvist R, et al. PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS. Journal of Medical Genetics 2016;53:800-11.
  43. Thompson PA, Levy V, Tam CS, et al. Atrial fibrillation in CLL patients treated with ibrutinib. An international retrospective study. British Journal of Haematology 2016;175:462-6.
  44. Trubiano JA, Aung AK, Nguyen M, et al. A Comparative Analysis Between Antibiotic- and Nonantibiotic-Associated Delayed Cutaneous Adverse Drug Reactions. Journal of Allergy and Clinical Immunology: In Practice 2016;4:1187-93.
  45. Trubiano JA, Worth LJ, Urbancic K, et al. Return to sender: the need to re-address patient antibiotic allergy labels in Australia and New Zealand. Internal Medicine Journal 2016;46:1311-7.
  46. Turner J, Kelly B, Clarke D, et al. A tiered multidisciplinary approach to the psychosocial care of adult cancer patients integrated into routine care: the PROMPT study (a cluster-randomised controlled trial). Supportive Care in Cancer 2017;25:17-26.
  47. Turnidge JD, Thursky K, Chen CS, McNeil VR, Wilkinson IJ. Antimicrobial use in Australian hospitals: how much and how appropriate? Medical Journal of Australia 2016;205:S16-S20.
  48. Violet JA, Farrugia G, Skene C, White J, Lobachevsky P, Martin R. Triple targeting of Auger emitters using octreotate conjugated to a DNA-binding ligand and a nuclear localizing signal. International Journal of Radiation Biology 2016;92:707-15.
  49. Wen SW, Sceneay J, Lima LG, et al. The Biodistribution and Immune Suppressive Effects of Breast Cancer-Derived Exosomes. Cancer Research 2016;76:6816-27.
  50. Xie J, Molck C, Paquet-Fifield S, et al. High expression of TROP2 characterizes different cell subpopulations in androgen-sensitive and androgen-independent prostate cancer cells. Oncotarget 2016;7:44492-504.
  51. Zdenkowski N, Tesson S, Lombard J, et al. Supportive care of women with breast cancer: key concerns and practical solutions. Medical Journal of Australia 2016;205:471-5.
Details